| Name | Title | Contact Details |
|---|
OptimizeRx® (OPRX) provides unique physician and consumer platforms and strategies to help patients better afford and adhere to their treatment regimens, while offering pharmaceutical and healthcare companies more effective ways to deliver relevant information and services to healthcare providers and their patients right at the point of care.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
CirrusMD is the nation`s leading Virtual Care Platform that empowers efficient and more meaningful connections between patients and their healthcare providers.
ALSM is a not-for-profit organization that has been serving families for 60 years. Our services and programs now span eight counties including Bedford, Blair, Cambria, Centre, Clearfield, Fulton, Huntingdon, and Somerset. ALSM currently offers care at